Background and activities

Scientific, academic and artistic work

A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database

Journal publications

  • Lamvik, Jon; Waage, Anders; Freim Wahl, Sissel; Næss, Inger Anne; Quist-Paulsen, Petter; Hammerstrøm, Jens. (2006) Adult acute lymphoblastic leukemia, Burkitt's lymphoma and lymphoblastic lymphoma in middle Norway 1985-2004. Haematologica. vol. 01.
  • Hammerstrøm, Jens; Aasland, Irene Line; Telhaug, Ragnar; Moen, Torolf; Lødemel, Bottolf; Sørum, Yngve; Brudevold, Robert; Herlofsen, Oluf; Sørbø, Jon Hjalmar; Almvik, Turid; Lamvik, Jon. (2004) Høydosebehandling med stamcellestøte i Midt-Norge. Tidsskrift for Den norske legeforening.
  • Lamvik, Jon. (2003) Vitenskapsmenn i Samarkan. Tidsskrift for Den norske legeforening.
  • Lamvik, Jon; Hjort, Peter F. (2003) Politikk, personlig ansvar og egen helse. Tidsskrift for Den norske legeforening.
  • Gulbrandsen, N.; Wisløff, Finn; Brinch, Lorentz; Carlson, K.; Dahl, Inger-Marie S.; Gimsing, P.; Hippe, E.; Hjorth, M.; Knudsen, L. M.; Lamvik, J.; Lenhoff, S.; Løfvenberg, E.; Nesthus, Ingerid; Lanng Nielsen, J.; Turesson, I.; Westin, J.. (2001) Health-Related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Medical Oncology. vol. 18 (1).
  • Gulbrandsen, Nina; Wisløff, Finn; Brinch, Lorentz; Carlson, K.; Dahl, Inger-Marie; Gimsing, P.; Hippe, E.; Hjorth, M.; Knudsen, L.M.; Lamvik, J.; Lenhoff, S.. (2001) Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support. Medical Oncology. vol. 18 (1).
  • Lamvik, Jon; Hella, Hanne; Liabakk, Nina-Beate; Halaas, Øyvind. (2001) Nonlabeled Secondary Antibodies Augment/Maintain the binding of Primarym Specific Antibodies to Cell Membrane Antigens. Cytometry. vol. 45.
  • Gulbrandsen, Nina; Wisløff, Finn Georg B; Brinch, Lorentz; Carlson, Kristina; Dahl, Inger Marie; Gimsing, Peter; Hippe, Erik; Hjorth, Martin; Knudsen, Lene; Lamvik, Jon; Lenhoff, Stig; Löfvenberg, E.; Nesthus, Ingerid; Lanng-Nielsen, Johan; Turesson, Ingemar; Westin, Jan. (2001) Health-related quality of life in multiple myeloma patients receiving high dose chemotherapy with autologous blood stem cell support. Medical Oncology. vol. 18.
  • Lenhoff, Stig; Hjorth, Martin; Holmberg, E.; Turesson, Ingemar; Westin, Jan; Wisløff, Finn Georg B; Brinch, Lorentz; Carlson, I.; Dahl, I.M.S.; Lamvik, Jon; Nesthus, I.. (2000) Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population based study. Blood. vol. 95.
  • Hjort-Hansen, Henrik; Seidel, Carina; Lamvik, Jon; Børset, Magne; Sundan, A.; Waage, Anders. (1999) Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia. European Journal of Haematology. vol. 62.
  • Hjorth-Hansen, Henrik; Seidel, Carina; Lamvik, Jon; Børset, Magne; Sundan, Anders; Waage, Anders. (1999) Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia. European Journal of Haematology.
  • Lamvik, Jon; Brinch, Lorentz; Dahl, Inger Marie S.; Sjo, Malvin; Nesthus, Ingerid; Tangen, Jon-Magnus; Berentsen, Sigbjørn; Ly, Bernt; Shammas, Fuad Victor. (1999) Kronisk myelogen leukemi i helseregion 1, 3, 4 og 5 i perioden 1990-96. Tidsskrift for Den norske legeforening.
  • Lamvik, Jon; Brinch, Lorentz; Dahl, Inger Marie S.; Sjo, Malvin; Nesthus, Ingerid; Tangen, Jon-Magnus; Berentsen, Sigbjørn; Ly, Bernt; Shammas, Fuad Victor. (1999) Kronisk myelogen leukemi i helseregion 1, 3, 4 og 5 i perioden 1990-96. Tidsskrift for Den norske legeforening.
  • Lamvik, Jon. (1998) Recruitment to medical research. Tidsskrift for Den norske legeforening. vol. 118 (20).
  • Tangen, Jon-Magnus; Abdelnoor, Michel; Brinch, Lorentz; Dahl, Inger Marie; Lamvik, Jon; Ly, Bernt; Nesthus, Ingerid; Wisløff, Finn Georg B. (1997) Survival of 86 patients, aged 15-60, with primary acute myelogenous leukaemia, treated with a common program in the Norwegian health regions I,III, IV and V in the period 1990-95. European Journal of Haematology. vol. 59.
  • Hjorth, Martin; Westin, Jan; Dahl, I.M.S.; Gimsing, P; Hippe, Erik; Holmberg, E.; Lamvik, Jon; Wisløff, Finn Georg B. (1996) Interferon alfa 2b added to malphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. Annals of Internal Medicine. vol. 124.
  • Waage, Anders; Dahl, I.M.S.; Evensen, Stein A.; Holte, H.; Lamvik, Jon; Sletnes, Kari; Wiløff, F.. (1996) Behandling med vekstfaktorer og cytokiner ved hematologiske lidelser. Tidsskrift for Den norske legeforening. vol. 116.
  • Wisløff, F.; Brinch, L.; Bruserud, Øystein; Dahl, Inger-Marie S; Lamvik, J.. (1994) Høydosebehandling med autolog stamcellestøtte ved maligne sykdommer. Tidsskrift for Den norske legeforening. vol. 114.
  • Austgulen, Rigmor; Lamvik, J. (1988) Behandling av kreft med biologiske regulatorsubstanser. Tidsskrift for Den norske legeforening. vol. 108.

Books

  • Carstens, Svein; Grankvist, Rolf; Lamvik, Jon; Aase, Monica. (2002) St.Olavs Hospital: Sykehuset på Øya gjennom 100 år. 2002.